N-of-1 Personalized Therapy for CMT2S: From Preclinical Models to First-in-Human Dosing by Anthony Palmeri | Oct 19, 2026
Beyond Patient-Reported Outcomes: Defining Meaningful Clinical Endpoints in CMT by Anthony Palmeri | Oct 19, 2026
DANCER: A New, Patient-Partnered Platform for Clinical Trials in CMT by Anthony Palmeri | Oct 19, 2026
Clinical Outcome Measures and Biomarkers for CMT: Are We Ready for Clinical Trials? by Anthony Palmeri | Oct 19, 2026
Patient Perspectives to Inform Therapeutic Development and Trial Design by Anthony Palmeri | Oct 19, 2026Researchers designing the next CMT trials hear directly from the patients those trials are meant to serve.
